Rothfels Heike, Paschen Annette, Schadendorf Dirk
Skin Cancer Unit of the German Cancer Research Center (DKFZ) at the University Hospital Mannheim, Mannheim, Germany.
Exp Dermatol. 2003 Dec;12(6):799-810. doi: 10.1111/j.0906-6705.2003.00093.x.
Selective killing of tumors can be achieved by targeting the transcription of suicide genes via specific DNA control elements to malignant cells. Three different enhancer-promoter systems were constructed and evaluated for their capability to direct gene expression to melanoma. Two tissue-specific (tyrosine and MIA) promoters and one weak viral promoter were fused to multiple tandem copies of a melanocyte-specific enhancer element. Reporter gene assays revealed a maximum increase in transcription by combining each promoter with 3-4 copies of the enhancer and demonstrated that all enhancer-promoter combinations exhibited tissue-specific activity. Though this activity was still significantly less than that of the strong but unspecific cytomegalovirus (CMV) promoter. In contrast, when those combinations were employed to drive the expression of two suicide genes, encoding the diptheria toxin A chain (DT-A) and the prodrug-activating herpes simplex virus thymidine kinase (TK), respectively, only those constructs in which transcription was under control of tissue-specific promoter elements mediated selective killing of melanoma cells. This killing was in the range of cell death induced by CMV promoter activity. Our data indicate that the enhancer/tyrosinase and enhancer/MIA promoter constructs but not the viral promoter constructs can provide a valuable tool for selective suicide gene expression in melanoma.
通过经由特定的DNA控制元件将自杀基因的转录靶向恶性细胞,可以实现肿瘤的选择性杀伤。构建了三种不同的增强子-启动子系统,并评估了它们将基因表达导向黑色素瘤的能力。将两个组织特异性(酪氨酸和黑色素瘤抑制活性蛋白)启动子和一个弱病毒启动子与黑色素细胞特异性增强子元件的多个串联拷贝融合。报告基因检测显示,将每个启动子与3-4个增强子拷贝组合时转录有最大程度的增加,并表明所有增强子-启动子组合均表现出组织特异性活性。尽管这种活性仍明显低于强但非特异性的巨细胞病毒(CMV)启动子的活性。相比之下,当使用这些组合来驱动分别编码白喉毒素A链(DT-A)和前药激活单纯疱疹病毒胸苷激酶(TK)的两个自杀基因的表达时,只有那些转录受组织特异性启动子元件控制的构建体介导了黑色素瘤细胞的选择性杀伤。这种杀伤作用与CMV启动子活性诱导的细胞死亡范围相当。我们的数据表明,增强子/酪氨酸酶和增强子/黑色素瘤抑制活性蛋白启动子构建体而非病毒启动子构建体可为黑色素瘤中选择性自杀基因表达提供有价值的工具。